Referral Criteria
Obesity by any definition, or Overweight plus a comorbidity
Must have had a recent primary care visit
Patients will schedule at the front desk, NOT through an Epic referral
Patients must be interested in visiting IMA Weight Management a total of 4 times
Antiobesity Medications
FDA-approved antiobesity medications
BMI >= 30 or >= 27 + 1 comorbidity
- Zepbound (tirzepatide)
- Wegovy (semaglutide)
- Saxenda (liraglutide)
- Qsymia (phentermine/topiramate)
- Contrave (naltrexone/bupropion)
- Orlistat
Medicaid in the State of NY and Medicare in the US does NOT cover ANY FDA-approved antiobesity medication.
Caveats: Wegovy 0.25mg and 0.5mg are widely on back order. Liraglutide has some recent data demonstrating increased pancreatitis, SBO, and gastroparesis.
The following GLP1RA will be denied for patients without T2DM: Ozempic, Trulicity, Bydureon, Mounjaro.
Off-label antiobesity medications
- metformin
- separately prescribed phentermine/topiramate
- separately prescribed naltrexone/bupropion
- phentermine
Reference: .ANTIOBESITYMEDICATIONS
At most ~$30 per month with GoodRx.
Questions
Reach out to Christine Schindler or Shyam Sundaresh
Employee Program for anyone prescribed an AOM
p Employee Health Pharmacists